CELLULAR BIOMEDICINE GROUP, INC. Increase (Decrease) in Restricted Cash
CELLULAR BIOMEDICINE GROUP, INC. reported Increase (Decrease) in Restricted Cash of -$6.41 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2020-11-09
- 2020-09-30: Increase (Decrease) in Restricted Cash 9 month -$6.41M.
- 2019-09-30: Increase (Decrease) in Restricted Cash 9 month -$6.78M.
| Period end | Increase (Decrease) in Restricted Cash 9 month |
|---|---|
| 2020-09-30 | -$6.41M 10-Q · filed 2020-11-09 |
| 2019-09-30 | -$6.78M 10-Q · filed 2020-11-09 |